| answer text |
<p>No specific assessment has been made of the barriers affecting access to the most
innovative treatments for patients with multiple myeloma.</p><br /><p>It is essential
that a robust process is in place to ensure that patients get rapid access to the
most innovative drugs that represent value for money to the National Health Service.
The Cancer Drugs Fund has helped over 84,000 people to access the life-extending drugs
they need, and NHS England and the National Institute for Health and Care Excellence
are currently consulting on the future shape of the Fund to put it on a more sustainable
footing.</p>
|
 |
